User
Information for Reviewer
Index

JKB telah terindex di Crossref JKB telah terindex di Google Scholar JKB telah terindex di SINTA Ristekdikti JKB telah terindex di Portal Garuda

Notifications
Journal Content

Browse
Visitor Counter

 

PROFIL KADAR SOLUBLE UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR (suPAR) PADA SERUM PENDERITA TUBERKULOSIS PARU (SEBAGAI MONITORING TERAPI)

Triwahju Astuti, Tri Yudani MR, Wibi Riawan, Nunuk Sri Muktiati, Edy Widjajanto
  Jurnal Kedokteran Brawijaya, Vol 24, No 1 (2008),  pp.30-35  

Abstract


Dutch study shows that Upar expression content is significantly higher in tubercolusis patient’s psiphsy monosit compared to those in the healthy control group. So far, there is no biologic marker used whichcan accurately observe response improvement in the treatment of lung tubercolusis. The aim of this research is to investigate whether the serum level of soluble utokinase plasminogen activator receptor (suPAR) carries information in monitoring TB treatment for Lung Tuberculosis patients. suPAR was measured by ELISA in 21 individuals at the time of enrolment into observational cross sectional based on active tuberculosis  and 5 individuals as healthy control. There were 3 groups, 1). patients who had not started treatment (n=7),2). patients who had been treated for 2 months (n=7),  3). patients who had been treated for 6 months (n=7). Among groups, there were no difference in mean of body mass index, erythrocyte sedimentation rate and monocyte count. Patients positive for TB on direct  microscopy were 29% ( 6 from 21 patients) , 2 patients each groups. The suPAR levels were elevated in patients with active TB compared to healthy control (P<0,001). suPAR levels were highest in patients positive for TB on direct microscopy ( mean suPAR 4.455 ng/ml).

Full Text:

PDF

References


Perhimpunan Dokter Paru Indonesia. Pedoman Diagnosis Dan Penatalaksanaan di Indonesia. Jakarta: Indah Offset Citra Grafika, 2006. h. 1-64.

Chandrawati H. Hubungan Body Mass Index dan lajuendap darah (LED) pada penderita tuberkulosis paru sesudah pengobatan antituberkulosis 6 bulan. Malang: Universitas Brawijaya, 2006. h. 42-52.

Sidenius N, Sier CFM, Ullum H, Pedersen BK, Lepri AC, Blasi F, et al. Serum level of soluble urokinase-type plasminogen activator receptor of survival in human immunodeficiency virus infection. The America Society of Hematology 2000: 4091-4095.

Siawaya. JFB, Ruhwald M, Eugen-Olsen J, Walzi G,Correlates for disease progression and prognosis during concurrent HIV/TB infection. International Journal of Infectious Diseases, 2007, 11 : 289-299

Olsen JE, Gustafson P, Sidenius N, Fischer TK, Parner J, Aaby P.The serum level of soluble urokinase receptor is elevated in tuberculosis patients and predict mortality during treatment: a community study from Guinea-Bissau.Int J Tuberc Lung Dis 2002; 6(8):686-692.

Schlesinger LS. Phagocytosis and toll-like receptor in tuberculosis. In: Rom WN, Garay SM. Tuberculosis. Philadelphia: Lippincott Williams and Wilkins; 2004. p. 203-209.

GML, Rom WN, Ciotoli C, Talbot A, Martiniuk F, Cronstein B, et al. Mycobacterium tuberculosis alters expression of adhesion molecules on monocytic cells. Infection and Immunity. 1994; 62: 2515-2520.

Ramirez GML, Rom WN, Ciotoli C, Talbot A, Martiniuk F, Cronstein B, et al. Mycobacterium tuberculosis alters expression of adhesion molecules on monocytic cells. Infection and Immunity. 1994; 62: 2515-2520.

Basuki SA, Pradjoko I. Perbandingan Efektifitas Penegakan Diagnosis Tuberkulosis Paru Melalui Metode Pengumpulan Dahak Sewaktu-Pagi-Sewaktu (SPS) dan Pagi-Pagi-Pagi (PPP) Pada Penderita Rawat Inap Di RSU Dr.Soetomo. Konker XI PDPI 2007. 177-181.

Juffermans NP, Dekkers PEP, Verbon A, Speelman,Deventer SJH, Poll T. Concurrent upregulation of urokinase plasminogen activator receptor and CD11b during Tuberculosis and experimental endotoxemia Infection and Immunity. 2001; 69: 5182-5185.

Juffermans NP, Verbon A, Speelman, Deventer SJH, Poll T. Elevated chemokine concentrations in seraof human immunodeficiency virus (HIV)-seropositive andHIV-seronegative patiens with Tuberculosis: a possible role for mycobacterial lipoarabinomannan. Infection and Immunity. 1999; 67: 4295-4297




DOI: http://dx.doi.org/10.21776/ub.jkb.2008.024.01.4

Refbacks

  • There are currently no refbacks.